Synthesis and structure-activity relationships of a new set of 2-arylpyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists

Journal of Medicinal Chemistry

Volumn 43, Issue 16, 2000, Pages 3118-3124

  Colotta, V ^a   Catarzi, D ^a   Varano, F ^a   Cecchi, L ^a   Filacchioni, G ^a   Martini, C ^b   Trincavelli, L ^b   Lucacchini, A ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; QUINOLONE DERIVATIVE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING, COMPETITIVE; CATTLE; CEREBRAL CORTEX; CHO CELLS; CRICETINAE; HUMANS; LIGANDS; QUINOLINES; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034632863     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm000936i     Document Type: Article

References (36)

1. Adenosine receptors: New opportunities for future drugs
2. Adenosine receptors-pharmacology, structure-activity relationships, and therapeutic potential
3. Adenosine receptor antagonists: Structures and potential therapeutic applications
4. 3 adenosine receptors
5. 3 receptor subtype
6. 3 receptor ligands. 1.3-(2-Pyridinyl)isoquinoline derivatives
7. 3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds
8. 1 receptor antagonist with potent diuretic activity
9. 1 antagonist. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure
10. Adenosine A(2A) receptor antagonists as new agents for the treatment of Parkinson's disease
11. Adenosine-A(3) receptors in mast-cells
12. 3 stimulation inhibits migration of human eosinophils
13. 3 receptor stimulation and cerebral ischemia
14. 3 receptor antagonists and protection cerebral ischemic damage in gerbils
15. 2 adenosine receptor antagonist
16. Novel adenosine receptor ligands: 1,3-Disubstituted[1]benzopyrano[2,3-c]pyrazol-4-ones. Synthesis and structure-activity relationships
17. 1 and A(2a) adenosine binding activity
18. 1 and A(2a) adenosine binding activities of some 1-aryl-1,4-dihydro-3-methyl[1]benzopyrano[2,3-c]pyrazol-4-ones, 1-aryl-4,9-dihydro-3-methyl- 1H-pyrazolo [3,4-b] quinolin-4-ones, and 1-aryl-1H-imidazo[4,5-b]quinoxalines
19. 1 receptors
20. 1,2,4-Triazolo[4,3-a]-quinoxalin-1-one: A versatile tool for the synthesis of potent and selective adenosine receptor antagonists
21. Tricyclic heteroaromatic systems. Pyrazolo-[3,4-c]quinolin-4-ones and pyrazolo[3,4-c]quinoline-1,4-diones: Synthesis and central benzodiazepine receptor activity
22. Synthesis of alkyltryptophans and nortryptophans
23. 3 adenosine receptor
24. 3 adenosine receptor with widespread tissue distribution
25. 3-adenosine receptors
26. 1 adenosine receptors purified from human brain membranes
27. Comparative pharmacology of human adenosine receptor subtypes-characterization of stably transfected receptors in CHO cells
28. New substituted 9-alkylpurines as adenosine receptor ligands
29. Structure-activity profile of a novel triazoloquinazoline adenosine antagonists
30. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants
31. 1-adenosine receptor antagonists
32. 3 adenosine receptor antagonists
33. 1 and A(2A) adenosine binding activity of some pyrano[2,3-c]pyrazol-4-ones
34. 3 adenosine receptors
35. Protein measurement with Folin phenol reagent
36. 50) of an enzyme reaction